• Dexcom G7 / Freestyle Libre 3 - Next Generation Continuous Glucose Moni

    From _@21:1/5 to All on Wed Jul 21 11:41:10 2021
    First off, commendations to Dexcom CEO
    Kevin Sayer saying “The enthusiasm here
    is at an all-time high for a new product.”
    “We’re ready to go. It’s really going to be
    wonderful.” (article dated July 19 2021) https://www.drugdeliverybusiness.com/dexcom-ceo-kevin-sayer-says-g7-will-be-wonderful/

    Unfortunately, unknown when it will be avail-
    able in the U.S., as that article says "Accord-
    ing to Sayer, Dexcom expects to launch G7
    later this year in Europe, with the expected
    financial impact to come in 2022. ..."

    Not one word about the U.S., unfortunately
    reminding me of the absolute total lack of
    information from Abbott regarding when its
    new advanced Freestyle Libre 3 will be avail-
    able in the U.S. (approved in Europe in Octo-
    ber 2020).

    Now, granted, Europe's population is 748
    million, the U.S. is 331 million, so it's clear
    to see why Europe is such a high priority,
    but still, I continue to be disappointed by the
    relative slowness of new CGMs making their
    way into the hands of Americans.

    ~~~ ~~~ ~~~ ~~~ ~~~ ~~~ ~~~ ~~~ ~~~

    INSULINITIS (ISLIT)

    New SUPERIOR clarifying name for near-
    total to total loss of endogenous insulin https://prohuman.net/pix2/new_superior_clarifying_name_is_INSULINITIS.jpg

    The overwhelming majority of Islit caused
    by autoimmune attacks on pancreatic beta
    cells (Insulitis Islit) but there are

    o 15 specific types of rapid onset Islit, a
    rare condition (only present in < one-half
    of 1% of Americans & in a much lower rate
    in most of the world), when present is typ-
    ically diagnosed at age under 30
    (50% at age < 18, 20% at age 19 to 29)

    o 1 slow onset specific type, Latent Auto-
    immune Islit, frequency unknown but per
    a recent report, misdiagnosed as Cellosis
    (new clarifying name for type 2 diabetes)
    almost 40% of the time due to slow onset
    & occurrence typically at age over 30

    Old outdated anachronistic name for Islit is
    type 1 diabetes, confusing in that diabetes
    without clarifier is often used to describe this
    & the other 6 Disparate High Glucose Con-
    ditions (DHGCs).

    That makes figuring out which DHGC is actu-
    ally being referred to (& it can be any 1, some,
    or all of them when diabetes or diabetic word
    used without clarifier) confusing / difficult: https://prohuman.net/pix2/diabetesdiabeticguessinggame.jpg https://prohuman.net/pix2/diabetesdiabeticconfusion.jpg https://prohuman.net/pix2/diabetesdiabeticendingthemisunderstanding.jpg

    Recent estimate that 20 million have Islit in the
    world, 1 in 394 (2.583/10ths of 1%), less than
    5% of the almost 470 million in the world who
    have any of the 7 DHGCs, 95% having Cellosis
    (see below for causalities): https://groups.google.com/g/misc.health.diabetes/c/58ZoHZEZ51w/m/EBejqoJQAQAJ

    Notably, one's relatives and one's birthplace
    dramatically impact one's risk of getting the
    Insulitis-caused Islit, as listed in details of all
    15 specific types of rapid-onset Islit & the sole
    specific type of slow onset Latent Autoimmune
    Islit at https://groups.google.com/g/misc.health.diabetes/c/aOsrugeqYqs/m/MlI8I6PzAAAJ

    - - -

    Insulin / Insulin Pump / CGM I use

    Fiasp Ultra-Fast-Acting Insulin in a tubeless
    Omnipod insulin pump catheter placed into
    skin / pod with adhesive stuck onto skin every
    80 hours, control via PDM (Personal Data
    Manager) https://prohuman.net/pix2/Fiaspinsulin_tubelessOmnipodDASHinsulinpump.jpg

    Dexcom G6 CGM (continuous glucose monitor) https://prohuman.net/pix2/Dexcom_G6_CGM.jpg

    - - -

    Stop Diabetes/Diabetic Confusion
    with New Superior Clarifying Terms https://www.change.org/stopdiabetesdiabeticconfusionwithNewSuperiorClarifyingTerms

    - - -

    o Preventable Cellosis is the only specific
    type of Disparate High Glucose Condition
    that is preventable & reversible (in many,
    sometimes it's called type 2 diabetes, often
    confusingly called diabetes with no clarifier)

    Risk for Preventable Cellosis, Hypertension,
    & Cardiovascular Disease increases as one's
    weight increases but BMI risk increases at
    lower BMI levels in non-white individuals: https://prohuman.net/pix2/BMI-WaistCircumference-Cellosis&Hypertension&CardiovascularDisease-Risk.jpg
    https://medicalxpress.com/news/2021-05-bmi-offs-obesity-diabetes-non-white.html

    o PreCellosis (often confusingly called predia-
    betes with no clarifier) is the oft-times preven-
    table & reversible Cellosis precondition that all-
    too-often the overwhelming majority having it
    are unaware they have it (almost 3 times more
    have PreCellosis than have Cellosis).

    o 20 specific types of Cellosis, unpreventable
    & nonreversible (thus far, sometimes called
    type 2 diabetes, all-too-often confusingly called
    diabetes with no clarifier)

    Per the following article, 5.3% with Cellosis
    used exogenous insulin in 2019. https://www.bloomberg.com/press-releases/2019-12-13/tandem-diabetes-care-announces-fda-clearance-of-the-t-slim-x2-insulin-pump-with-control-iq-advanced-hybrid-closed-loop

    - - -

    o 4 other Disparate High Glucose Conditions
    exist (Gestational Cellosis, Diminosis, Neonatal
    Diminosis, Ohiglucons), all 7 DHGCs fully des-
    cribed in the following article:

    Logic and reasoning behind ceasing using
    confusing / misleading / misinforming diabetes
    & diabetic & reactive hypoglycemia words and
    phrases, replacing all of that with vastly superior
    clarifying names:

    Diabetes Bubble / Diabetes Bubble Burst https://prohuman.net/diabetesbubblediabetesbubbleburst.htm

    ~~~ ~~~ ~~~ ~~~ ~~~ ~~~ ~~~ ~~~ ~~~

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)